Mesa Laboratories Company Insiders

MLAB Stock  USD 131.25  4.15  3.06%   
Mesa Laboratories' insiders are aggressively selling. The analysis of insiders' sentiment of trading Mesa Laboratories stock suggests that all insiders are panicking at this time. Mesa Laboratories employs about 736 people. The company is managed by 7 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 105.14 employees per reported executive.
Gary Owens  President
COO, Vice President

Mesa Laboratories' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-10-28Gary M OwensDisposed 2518 @ 113.62View
2024-09-13Brian David ArchboldDisposed 1499 @ 125View
Monitoring Mesa Laboratories' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

Mesa Laboratories' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Mesa Laboratories' future performance. Based on our forecasts, it is anticipated that Mesa will maintain a workforce of about 740 employees by January 2025.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Mesa Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of 0.0169 % which means that it generated a profit of $0.0169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8946) %, meaning that it created substantial loss on money invested by shareholders. Mesa Laboratories' management efficiency ratios could be used to measure how well Mesa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -1.58. The current year's Return On Capital Employed is expected to grow to -0.64. At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 354.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 823.6 K.
As of December 25, 2024, Common Stock Shares Outstanding is expected to decline to about 4.3 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 1 M

Mesa Laboratories Workforce Comparison

Mesa Laboratories is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 9,167. Mesa Laboratories holds roughly 736 in number of employees claiming about 8% of equities under Health Care industry.

Mesa Laboratories Profit Margins

The company has Profit Margin (PM) of (1.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.690.6164
Moderately Up
Slightly volatile

Mesa Laboratories Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mesa Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mesa Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Mesa Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.5
1
2
 11,559 
 5,069 
2024-09-01
1.1538
15
13
 20,746 
 15,561 
2024-06-01
0.4286
6
14
 48,626 
 17,551 
2024-03-01
0.5
1
2
 724.00 
 290.00 
2023-12-01
0.3333
1
3
 200.00 
 3,700 
2023-09-01
1.3333
16
12
 28,630 
 16,216 
2023-06-01
0.3636
12
33
 36,719 
 11,952 
2023-03-01
0.5
9
18
 24,279 
 36,549 
2022-12-01
0.3333
1
3
 40.00 
 4,155 
2022-09-01
0.963
26
27
 26,831 
 30,130 
2022-06-01
0.7931
23
29
 63,961 
 24,570 
2022-03-01
0.5
5
10
 8,792 
 18,184 
2021-12-01
0.6667
16
24
 34,712 
 30,424 
2021-09-01
1.25
30
24
 57,923 
 28,544 
2021-06-01
0.6429
36
56
 45,892 
 51,269 
2021-03-01
0.3529
6
17
 27,225 
 40,541 
2020-12-01
0.7333
22
30
 10,233 
 19,630 
2020-09-01
0.5172
15
29
 10,448 
 16,979 
2020-06-01
1.9412
33
17
 36,089 
 4,787 
2020-03-01
0.6
9
15
 12,680 
 32,963 
2019-12-01
1.6
16
10
 4,873 
 14,434 
2019-09-01
1.0
2
2
 2,720 
 2,720 
2019-06-01
0.8611
31
36
 32,561 
 14,431 
2019-03-01
0.3333
8
24
 12,084 
 33,332 
2018-12-01
1.3636
15
11
 3,770 
 20,650 
2018-09-01
0.4444
4
9
 3,920 
 287,462 
2018-06-01
4.5
27
6
 35,370 
 30,989 
2018-03-01
0.3077
4
13
 5,800 
 50,300 
2017-09-01
0.1
1
10
 2,000 
 8,610 
2017-06-01
2.125
17
8
 42,980 
 26,700 
2017-03-01
0.3684
7
19
 27,914 
 62,062 
2016-12-01
0.3
3
10
 4,567 
 15,136 
2016-06-01
1.6667
15
9
 35,259 
 10,434 
2016-03-01
0.1667
1
6
 1,903 
 7,812 
2015-12-01
0.9167
11
12
 16,638 
 19,038 
2015-09-01
0.1
1
10
 150.00 
 69,627 
2015-06-01
1.3529
23
17
 57,675 
 12,545 
2015-03-01
1.0
2
2
 1,950 
 1,950 
2014-12-01
1.3333
12
9
 5,370 
 8,650 
2014-09-01
1.0
2
2
 14,000 
 14,000 
2014-06-01
4.0
16
4
 38,700 
 1,500 
2014-03-01
0.3333
2
6
 14,925 
 30,925 
2013-12-01
0.4118
7
17
 8,925 
 41,800 
2013-09-01
0.625
5
8
 19,000 
 33,000 
2013-06-01
4.0
12
3
 22,550 
 1,350 
2013-03-01
0.5556
5
9
 10,275 
 43,001 
2012-12-01
0.2727
3
11
 11,240 
 48,271 
2012-06-01
1.9
19
10
 34,875 
 13,075 
2012-03-01
1.4
14
10
 27,180 
 38,264 
2011-06-01
1.7692
23
13
 45,875 
 22,225 
2011-03-01
2.0
2
1
 20,000 
 10,000 
2010-12-01
2.0
10
5
 152,775 
 70,985 
2010-06-01
2.0
20
10
 42,600 
 15,522 
2010-03-01
0.4
2
5
 5,025 
 10,369 
2009-12-01
0.6667
10
15
 55,475 
 48,864 
2009-06-01
2.5
10
4
 29,000 
 6,175 
2008-12-01
0.4
2
5
 11,940 
 18,000 
2008-09-01
1.0
2
2
 1,750 
 1,750 
2008-06-01
2.5
10
4
 20,475 
 105,500 
2007-12-01
0.2222
2
9
 4,000 
 32,630 
2007-09-01
1.0
6
6
 5,500 
 11,750 
2007-06-01
1.75
7
4
 53,000 
 14,000 
2007-03-01
0.8333
5
6
 4,400 
 7,425 
2006-12-01
0.6667
4
6
 10,500 
 15,700 
2006-06-01
1.3333
8
6
 16,100 
 8,000 
2006-03-01
1.0667
16
15
 77,100 
 75,846 
2005-12-01
1.1111
10
9
 21,832 
 21,000 
2005-09-01
0.5
1
2
 1,500 
 1,974 
2005-06-01
7.0
7
1
 20,000 
 675.00 
2004-12-01
0.4286
3
7
 7,500 
 32,840 
2004-09-01
1.0
5
5
 17,500 
 10,350 
2004-03-01
1.0
1
1
 4,000 
 4,000 
2003-12-01
0.8571
12
14
 36,000 
 43,200 

Mesa Laboratories Notable Stakeholders

A Mesa Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mesa Laboratories often face trade-offs trying to please all of them. Mesa Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mesa Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gary OwensCOO, Vice PresidentProfile
John SakysCFO, Chief Accounting Officer and SecretaryProfile
John CPACFO VPProfile
Peter DanskyPres GenomicsProfile
Brian ArchboldSenior ImprovementProfile
Bryan LeoVP OperationsProfile
Garrett KrushefskiVP OperationsProfile

About Mesa Laboratories Management Performance

The success or failure of an entity such as Mesa Laboratories often depends on how effective the management is. Mesa Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mesa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mesa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.66)(1.58)
Return On Capital Employed(0.68)(0.64)
Return On Assets(0.57)(0.54)
Return On Equity(1.75)(1.66)
Please note, the presentation of Mesa Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mesa Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mesa Laboratories' management manipulating its earnings.

Mesa Laboratories Workforce Analysis

Traditionally, organizations such as Mesa Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mesa Laboratories within its industry.

Mesa Laboratories Manpower Efficiency

Return on Mesa Laboratories Manpower

Revenue Per Employee293.7K
Revenue Per Executive30.9M
Net Loss Per Employee345.4K
Net Loss Per Executive36.3M
Working Capital Per Employee88.4K
Working Capital Per Executive9.3M

Complementary Tools for Mesa Stock analysis

When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules